Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeutics
Open Access
- 1 February 2016
- journal article
- review article
- Published by Elsevier BV in Annals of Oncology
- Vol. 27 (2), 233-240
- https://doi.org/10.1093/annonc/mdv572
Abstract
We review the available trial data for novel regimens, recently updated treatment guidelines, and the practical considerations for treatment selection in patients with Waldenström's macroglobulinemia (WM). This comprehensive review will help inform the modern management of patients with WM in the era of novel therapeutics and personalized therapy.Funding Information
- Onyx Pharmaceuticals, Inc.
- Onyx Pharmaceuticals, Inc.
This publication has 39 references indexed in Scilit:
- How to manage Waldenstrom’s macroglobulinemiaLeukemia, 2013
- Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumabBlood, 2011
- microRNA-dependent modulation of histone acetylation in Waldenström macroglobulinemiaBlood, 2010
- Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenström MacroglobulinemiaJournal of Clinical Oncology, 2010
- Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenström's MacroglobulinemiaClinical Cancer Research, 2010
- Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180Journal of Clinical Oncology, 2009
- Thalidomide and rituximab in Waldenstrom macroglobulinemiaBlood, 2008
- Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia patients: a population-based study in SwedenBlood, 2008
- Dual targeting of the proteasome regulates survival and homing in Waldenström macroglobulinemiaBlood, 2008
- The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemiaBlood, 2007